Bruce is a Partner at NewSpring Capital. Bruce was the Chairman and Chief Executive Officer at Barr Pharmaceuticals Inc. from 1994 to 2008. Prior to Barr, he was a Partner at Winston & Strawn LLP and Bishop, Cook, Purcell, and Reynolds. Bruce has been on the Board of Directors for Cardinal Health and Momenta Pharmaceuticals since 2009. He is also on the Board for Acetylon Pharmaceuticals, Inc. and OncoPep. Mr. Downey received a BS degree from Miami University and a JD from Ohio State University. Bruce was the Chairman of Generic Pharmaceutical Association from 2006 to 2007.